Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. (NASDAQ:AMGN)'s unique drug to treat osteoporosis in postmenopausal women at high risk of a fracture cleared the FDA hurdle after an earlier unsuccessful attempt.
The highlights of the week were presentations at the European Association for the Study of the Liver, or EASL, International Liver Congress held in Vienna, Austria.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Here are some key catalysts on tap for the unfolding week.
Conferences
- 2019 Muscular Dystrophy Association, or MDA, Clinical & Scientific Conference - April 13-17, at the Hyatt Regency in Orlando
- 29th European Congress of Clinical Microbiology & Infectious Diseases, or ECCMID - April 13-16 in Amsterdam, Netherlands
- World Vaccine Congress 2019 – April 14 – 17, in Washington
- 5th World Heart Congress – April 15-16, in Amsterdam
- 12th International Conference on Genomics and Molecular Biology - April 15-17, in Berlin, Germany
- 2019 ESM-EVBO (European Society for Microcirculation – European Vascular Biology Organization) Conference - April 15-18, at the MECC in Maastricht
Related Link: Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates
Clinical Trial Readouts
Wave Life Sciences Ltd (NASDAQ:WVE) is due to present new Phase 1 safety and tolerability data for WVE-210201 for Duchenne muscular dystrophy, or DMD, Exon 51 at the MDA Clinical & Scientific Conference.
Sarepta Therapeutics Inc (NASDAQ:SRPT) will present data on MYO-1 for DMD – LGMD2E at the 2019 MDA Clinical & Scientific Conference on April 16.
Novavax, Inc. (NASDAQ:NVAX) will present already-released Phase 3 top-line data for RSV vaccine in healthy pregnant women to protect infants via maternal immunization. The data released in late February showed that the primary endpoint was not met.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
ContraFect Corp (NASDAQ:CFRX) will present new Phase 2 data for CF-301 in treating serious infections caused by Staphylococcus aureus, including MRSA. The data is due to be presented April 16. The stock was one of the worst performers among biotechs in the first quarter.
SCYNEXIS Inc (NASDAQ:SCYX) is scheduled to present interim Phase 3 open-label data for SCY-078, oral, in invasive candidiasis at the ECCMID on April 16.
Earnings
Wednesday
- Abbott Laboratories (NYSE:ABT) (before the market open)
Thursday
- Intuitive Surgical, Inc. (NASDAQ:ISRG) (after the market close)
IPOs
Brainsway, a maker of medical devices that use magnetic stimulation to treat depression and obsessive-compulsive disorder, is set to offer 2.5 million shares in an IPO, with the price estimated between $9 and $11. Shares are to be listed on the Nasdaq under the ticker symbol "BWAY."
Turning Point Therapeutics, an early-stage biotech developing therapies to treat cancer, plans to offer 7.352 million shares in an IPO, with an estimated price range of $16-$18. The company seeks to list shares on the Nasdaq under the ticker symbol "TPTX."
Hookipa Pharma is gearing up for a 6.67-million share IPO, with an estimated price range of $14-$16. The developer of T cell immunotherapies for treating cancer and infectious diseases is due to list shares on the Nasdaq under the ticker symbol "HOOK."
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.